NO173046C - Fremgangsmaate for fremstilling av terapeutiske preparaterinneholdende 2-(2-fluor-4-bifenylyl)propionsyre - Google Patents

Fremgangsmaate for fremstilling av terapeutiske preparaterinneholdende 2-(2-fluor-4-bifenylyl)propionsyre

Info

Publication number
NO173046C
NO173046C NO863935A NO863935A NO173046C NO 173046 C NO173046 C NO 173046C NO 863935 A NO863935 A NO 863935A NO 863935 A NO863935 A NO 863935A NO 173046 C NO173046 C NO 173046C
Authority
NO
Norway
Prior art keywords
propionic acid
bifenylyl
fluor
procedure
preparation
Prior art date
Application number
NO863935A
Other languages
English (en)
Norwegian (no)
Other versions
NO173046B (no
NO863935L (no
NO863935D0 (no
Inventor
Graham Bird
Alan Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO863935D0 publication Critical patent/NO863935D0/no
Publication of NO863935L publication Critical patent/NO863935L/no
Publication of NO173046B publication Critical patent/NO173046B/no
Publication of NO173046C publication Critical patent/NO173046C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
NO863935A 1985-10-03 1986-10-02 Fremgangsmaate for fremstilling av terapeutiske preparaterinneholdende 2-(2-fluor-4-bifenylyl)propionsyre NO173046C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524421A GB8524421D0 (en) 1985-10-03 1985-10-03 Therapeutic agents

Publications (4)

Publication Number Publication Date
NO863935D0 NO863935D0 (no) 1986-10-02
NO863935L NO863935L (no) 1987-04-06
NO173046B NO173046B (no) 1993-07-12
NO173046C true NO173046C (no) 1993-10-20

Family

ID=10586136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863935A NO173046C (no) 1985-10-03 1986-10-02 Fremgangsmaate for fremstilling av terapeutiske preparaterinneholdende 2-(2-fluor-4-bifenylyl)propionsyre

Country Status (22)

Country Link
US (1) US4786495A (pt)
EP (1) EP0223369B1 (pt)
JP (1) JPS62111922A (pt)
KR (1) KR940000231B1 (pt)
AT (1) ATE59291T1 (pt)
AU (1) AU594264B2 (pt)
CA (1) CA1275930C (pt)
CS (1) CS271463B2 (pt)
DE (1) DE3676645D1 (pt)
DK (1) DK165165C (pt)
EG (1) EG17609A (pt)
ES (1) ES2033682T3 (pt)
FI (1) FI84314C (pt)
GB (1) GB8524421D0 (pt)
GR (1) GR3001312T3 (pt)
IE (1) IE59134B1 (pt)
IN (1) IN164030B (pt)
NO (1) NO173046C (pt)
NZ (1) NZ217703A (pt)
PT (1) PT83474B (pt)
RU (1) RU1800996C (pt)
ZA (1) ZA867309B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US5286751A (en) * 1987-12-24 1994-02-15 Analgesic Associates Sustained/enhanced antipyretic response
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) † 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
JP2001520984A (ja) * 1997-10-27 2001-11-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 水難溶性薬剤の固態溶剤及び固体分散体
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
DK1521572T3 (da) * 2002-07-15 2009-05-04 Alcon Inc Biologisk nedbrydelig film til indförsel af öjenlægemiddel
US7678827B2 (en) * 2002-07-15 2010-03-16 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
AU2003280960A1 (en) * 2002-07-15 2004-02-02 Alcon, Inc. Pharmaceutical compositions for otic use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3966978A (en) * 1975-04-25 1976-06-29 American Cyanamid Company 4-Biphenylacetic acid as an inhibitor of platelet aggregation
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
JPS5913720A (ja) * 1982-07-15 1984-01-24 Green Cross Corp:The フルルビプロフエン脂肪乳剤
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
IT1170238B (it) * 1982-12-06 1987-06-03 Upjohn Co Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
US4543251A (en) * 1983-12-09 1985-09-24 Toko Yakuhin Industry Co., Ltd. Gel preparations for external application
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
EP0275526A3 (en) * 1986-12-27 1990-01-31 Banyu Pharmaceutical Co., Ltd. Composition for administration through a body cavity

Also Published As

Publication number Publication date
AU6346586A (en) 1987-04-09
JPS62111922A (ja) 1987-05-22
JPH0428243B2 (pt) 1992-05-13
EP0223369A3 (en) 1987-12-02
IE59134B1 (en) 1994-01-12
EP0223369B1 (en) 1990-12-27
ES2033682T3 (es) 1993-04-01
PT83474B (pt) 1989-02-28
US4786495A (en) 1988-11-22
NO173046B (no) 1993-07-12
CS708386A2 (en) 1990-02-12
DK165165C (da) 1993-03-01
GB8524421D0 (en) 1985-11-06
CA1275930C (en) 1990-11-06
DE3676645D1 (de) 1991-02-07
DK165165B (da) 1992-10-19
NZ217703A (en) 1989-01-06
CS271463B2 (en) 1990-10-12
IN164030B (pt) 1988-12-31
GR3001312T3 (en) 1992-08-31
ZA867309B (en) 1987-05-27
FI863976A (fi) 1987-04-04
KR940000231B1 (ko) 1994-01-12
EG17609A (en) 1995-04-30
IE862449L (en) 1987-04-03
FI863976A0 (fi) 1986-10-01
AU594264B2 (en) 1990-03-01
FI84314C (fi) 1991-11-25
FI84314B (fi) 1991-08-15
RU1800996C (ru) 1993-03-07
NO863935L (no) 1987-04-06
DK453386A (da) 1987-04-04
EP0223369A2 (en) 1987-05-27
NO863935D0 (no) 1986-10-02
DK453386D0 (da) 1986-09-23
ATE59291T1 (de) 1991-01-15
KR870003772A (ko) 1987-05-04
PT83474A (en) 1986-11-01

Similar Documents

Publication Publication Date Title
NO863935L (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
MX9202215A (es) Composicion farmaceutica que comprende s(-) 2(4- iso butil fenil) propionato de sodio y proceso para su preparacion.
YU89891A (sh) SMEŠE TGF-beta
FR2381521A1 (fr) Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
SE8501518L (sv) Farmaceutiska preparat
NO933016D0 (no) Fremgangsmaate for sikker administrering av fettsyre
ES8308827A1 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
JPS56128731A (en) Ester of arylpropionic acid, manufacture and medicine of effective ingredient
IT8048484A0 (it) Derivati di alfa-alogenometilammino acidi ad attivita' farmaceutica eprocedimento per la loro preparazione
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
IT7822772A0 (it) Derivato furanico per impiego quale prodotto farmaceutico particolarmente per il trattamentodi malattie reumatiche e metodo per la sua preparazione.
IT1255236B (it) Composizione farmaceutica idrofila per uso topico
IT8021107A0 (it) Esteri di acidi, dialogenovinil-ciclopropancarbossilici, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi.
SE8802243D0 (sv) Farmaceutisk beredning

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees